Autor: "Siesling S" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design.
Autorzy:: Klaassen-Dekker A; Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, The Netherlands. .; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. .
Drossaert CHC; Health & Technology Department, University of Twente, Enschede, The Netherlands.
Van Maaren MC; Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, The Netherlands.
Van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Utrecht, The Netherlands.
Retel VP; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Korevaar JC; Faculty of Health, Nutrition & Sport, The Hague University of Applied Sciences, The Hague, The Netherlands.; Netherlands Institute for Health Services Research (NIVEL), Utrecht, the Netherlands.
Siesling S; Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Pokaż więcej
Corporate Authors:: NABOR project group
Źródło:: BMC cancer [BMC Cancer] 2023 Nov 14; Vol. 23 (1), pp. 1112. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/therapy
Humans ; Female ; Aftercare ; Quality of Life ; Prospective Studies ; Interrupted Time Series Analysis ; Multicenter Studies as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: 5-year adherence to adjuvant endocrine treatment in Dutch women with early stage breast cancer: A population-based database study (2006-2016).
Autorzy:: van den Biggelaar YJPG; Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.
Kuiper JG; PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands.
van der Sangen MJC; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands.
Luiten EJT; Department of Surgery, Breast Care Center Tawam Hospital, Abu Dhabi, United Arab Emirates.
Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.
van Herk-Sukel M; Department of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht, the Netherlands.
Voogd AC; Department of Epidemiology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.
Mesters I; Department of Epidemiology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.; Pokaż więcej
Źródło:: Breast disease [Breast Dis] 2023; Vol. 42 (1), pp. 331-339.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Female ; Humans ; Antineoplastic Agents, Hormonal/therapeutic use ; Treatment Outcome ; Chemotherapy, Adjuvant ; Tamoxifen/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: The value of time-dependent risk predictions in a screening context - a comprehensive simulation analysis validated on German cancer registry data.
Autorzy:: Voelkel V; Tumor Center Regensburg/ University of Regensburg, Institute for Quality Control and Health Services Research, Regensburg, Germany.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands.
Draeger T; Tumor Center Regensburg/ University of Regensburg, Institute for Quality Control and Health Services Research, Regensburg, Germany.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands.
van Mossel S; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands.
Siesling S; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Koffijberg H; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands. .; Pokaż więcej
Źródło:: BMC medical research methodology [BMC Med Res Methodol] 2022 Sep 10; Vol. 22 (1), pp. 239. Date of Electronic Publication: 2022 Sep 10.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/diagnosis
Early Detection of Cancer*
Female ; Humans ; Mass Screening ; Neoplasm Recurrence, Local ; Registries

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Surgeons' preferences for using sentinel lymph node biopsy in patients with ductal carcinoma in situ.
Autorzy:: Meurs CJC; CMAnalyzing, Zevenaar, the Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands.
Til JAV; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands.
Menke-Pluijmers MBE; Department of Surgery, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
Vet S; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands.
Siesling S; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Centre Organisation, Utrecht, the Netherlands.
Westenend PJ; Laboratory of Pathology Dordrecht, Dordrecht, the Netherlands.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Jun 06; Vol. 17 (6), pp. e0269551. Date of Electronic Publication: 2022 Jun 06 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/diagnosis
Breast Neoplasms*/pathology
Breast Neoplasms*/surgery
Carcinoma, Intraductal, Noninfiltrating*/pathology
Carcinoma, Intraductal, Noninfiltrating*/surgery
Surgeons*
Axilla/pathology ; Cross-Sectional Studies ; Female ; Humans ; Lymph Nodes/pathology ; Mammography ; Sentinel Lymph Node Biopsy/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Opportunities and obstacles in linking large health care registries: the primary secondary cancer care registry - breast cancer.
Autorzy:: Heins MJ; Nivel, Netherlands Institute of Health Services Research, P.O Box 1568, 3500 BN, Utrecht, Netherlands. .
de Ligt KM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands.
Verloop J; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands.
Korevaar JC; Nivel, Netherlands Institute of Health Services Research, P.O Box 1568, 3500 BN, Utrecht, Netherlands.; Pokaż więcej
Źródło:: BMC medical research methodology [BMC Med Res Methodol] 2022 Apr 27; Vol. 22 (1), pp. 124. Date of Electronic Publication: 2022 Apr 27.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/diagnosis
Breast Neoplasms*/epidemiology
Breast Neoplasms*/therapy
Delivery of Health Care ; Electronic Health Records ; Female ; Humans ; Information Storage and Retrieval ; Registries

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Diagnostics in Patients Suspect for Breast Cancer in The Netherlands.
Autorzy:: Voets MM; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE Enschede, The Netherlands.
Groothuis-Oudshoorn CGM; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE Enschede, The Netherlands.
Veneklaas LHJ; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE Enschede, The Netherlands.
Manohar S; Multi-Modality Imaging, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE Enschede, The Netherlands.
Brinkhuis M; Laboratory for Pathology East Netherlands, LabPON, Boerhaavelaan 59, P.O. Box 516, 7550 AM Hengelo, The Netherlands.
Veltman J; Department of Radiology, Ziekenhuisgroep Twente, Zilvermeeuw 1, P.O. Box 7600, 7609 PP Almelo, The Netherlands.
de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, P.O. Box 19079, 3501 DB Utrecht, The Netherlands.
de Geus-Oei LF; Department of Radiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands.; Biomedical Photonic Imaging Group, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE Enschede, The Netherlands.
Broeders MJM; Dutch Expert Centre for Screening, P.O. Box 6873, 6503 GJ Nijmegen, The Netherlands.; Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
Siesling S; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE Enschede, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, P.O. Box 19079, 3501 DB Utrecht, The Netherlands.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Nov 29; Vol. 28 (6), pp. 4998-5008. Date of Electronic Publication: 2021 Nov 29.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/diagnosis
Breast Neoplasms*/pathology
Cohort Studies ; Female ; Humans ; Netherlands ; Registries

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.
Autorzy:: Eijkelboom AH; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands.
de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands.
Vrancken Peeters MTFD; Department of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Surgery, Amsterdam UMC, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Broeders MJM; Department for Health Evidence, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.; Dutch Expert Centre for Screening, Wijchenseweg 101, 6538 SW, Nijmegen, The Netherlands.
Strobbe LJA; Department of Surgical Oncology, Canisius Wilhelmina Hospital, Weg door Jonkerbos 100, 6532 SZ, Nijmegen, The Netherlands.
Bos MEMM; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Guerrero Paez C; Dutch Breast Cancer Society (BVN), Godebaldkwartier 363, 3511 DT, Utrecht, The Netherlands.
Smidt ML; Department of Surgery, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX, Maastricht, the Netherlands.; GROW School for Oncology and Development Biology, Maastricht University, Univeristeitssingel 40, 6220 ER, Maastricht, the Netherlands.
Bessems M; Department of Surgery, Jeroen Bosch Hospital, Henri Dunantstraat 1, 5223 GZ, 's-Hertogenbosch, The Netherlands.
Verloop J; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands.
Linn S; Division of Diagnostic Oncology and Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Lobbes MBI; GROW School for Oncology and Development Biology, Maastricht University, Univeristeitssingel 40, 6220 ER, Maastricht, the Netherlands.; Department of Medical Imaging, Zuyderland Medical Center, Sittard-Geleen, Dr. H. van der Hoffplein 1, 6162 BG, Geleen, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands.
Honkoop AH; Department of Medical Oncology, Isala Clinics, Dokter van Heesweg 2, 8025 AB, Zwolle, The Netherlands.
van den Bongard DHJG; Department of Radiation Oncology, Amsterdam UMC, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Westenend PJ; Laboratory of Pathology, Karel Lotsyweg 145, 3318 AL, Dordrecht, The Netherlands.
Wesseling J; Division of Diagnostic Oncology and Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Menke-van der Houven van Oordt CW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location Vrije Universiteit Medical Centre, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Tjan-Heijnen VCG; Department of Medical Oncology, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands.
Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands. s.siesling@utwente.nl.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands. s.siesling@utwente.nl.; Pokaż więcej
Corporate Authors:: NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium
Źródło:: Journal of hematology & oncology [J Hematol Oncol] 2021 Apr 17; Vol. 14 (1), pp. 64. Date of Electronic Publication: 2021 Apr 17.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms/*diagnosis
Breast Neoplasms/*therapy
Adult ; Aged ; Breast Neoplasms/epidemiology ; Breast Neoplasms/pathology ; COVID-19/epidemiology ; Disease Management ; Female ; Humans ; Incidence ; Mass Screening ; Middle Aged ; Neoplasm Staging ; Netherlands/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Explainable machine learning can outperform Cox regression predictions and provide insights in breast cancer survival.
Autorzy:: Moncada-Torres A; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Zernikestraat 29, 5612 HZ, Eindhoven, The Netherlands. .
van Maaren MC; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Zernikestraat 29, 5612 HZ, Eindhoven, The Netherlands.; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands.
Hendriks MP; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Zernikestraat 29, 5612 HZ, Eindhoven, The Netherlands.; Department of Medical Oncology, Northwest Clinics, Alkmaar, The Netherlands.
Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Zernikestraat 29, 5612 HZ, Eindhoven, The Netherlands.; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands.
Geleijnse G; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Zernikestraat 29, 5612 HZ, Eindhoven, The Netherlands.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Mar 26; Vol. 11 (1), pp. 6968. Date of Electronic Publication: 2021 Mar 26.
Typ publikacji:: Journal Article
MeSH Terms:: Machine Learning*
Support Vector Machine*
Breast Neoplasms/*mortality
Registries/*statistics & numerical data
Risk Assessment/*methods
Breast Neoplasms/epidemiology ; Breast Neoplasms/pathology ; Female ; Humans ; Netherlands/epidemiology ; Prognosis ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Validating a generic cancer consumer quality index in eight European countries, patient reported experiences and the influence of cultural differences.
Autorzy:: Wind A; Rijnstate Hospital, Arnhem, The Netherlands. .
Hartman ED; Rijnstate Hospital, Arnhem, The Netherlands.; Department of Health Technology and Services Research, technical Medical Centre, Faculty of behavioural, management and social sciences (BMS), University of Twente, Enschede, The Netherlands.
Van Eekeren RRJP; Rijnstate Hospital, Arnhem, The Netherlands.
Wijn RPWF; Departement of Urology, Jeroen Bosch Hospital, Den Bosch, The Netherlands.
Halámková J; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Mattson J; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
Siesling S; Department of Health Technology and Services Research, technical Medical Centre, Faculty of behavioural, management and social sciences (BMS), University of Twente, Enschede, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
van Harten WH; Rijnstate Hospital, Arnhem, The Netherlands.; Department of Health Technology and Services Research, technical Medical Centre, Faculty of behavioural, management and social sciences (BMS), University of Twente, Enschede, The Netherlands.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2021 Mar 06; Vol. 21 (1), pp. 231. Date of Electronic Publication: 2021 Mar 06.
Typ publikacji:: Journal Article
MeSH Terms:: Cross-Cultural Comparison*
Patient Reported Outcome Measures*
Benchmarking/*statistics & numerical data
Breast Neoplasms/*therapy
Prostatic Neoplasms/*therapy
Adolescent ; Adult ; Aged ; Breast Neoplasms/psychology ; Cancer Survivors/psychology ; Cancer Survivors/statistics & numerical data ; Europe ; Female ; Humans ; Male ; Middle Aged ; Patient Safety/statistics & numerical data ; Patient Satisfaction/statistics & numerical data ; Prostatic Neoplasms/psychology ; Reproducibility of Results ; Uncertainty ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
Autorzy:: Dinmohamed AG; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands. .; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. .; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. .
Cellamare M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands.
Visser O; Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands.
Elferink MAG; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands.
Westenend PJ; Department of Pathology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.; Laboratory for Pathology Dordrecht, Dordrecht, The Netherlands.
Wesseling J; Divisions of Diagnostic Oncology and Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Broeders MJM; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Dutch Expert Centre for Screening, Nijmegen, The Netherlands.
Kuipers EJ; Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Merkx MAW; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Department of Oral and Maxillofacial Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
Nagtegaal ID; PALGA Foundation, Houten, The Netherlands.; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands. s.siesling@iknl.nl.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands. s.siesling@iknl.nl.; Pokaż więcej
Źródło:: Journal of hematology & oncology [J Hematol Oncol] 2020 Nov 04; Vol. 13 (1), pp. 147. Date of Electronic Publication: 2020 Nov 04.
Typ publikacji:: Letter
MeSH Terms:: Breast Neoplasms/*diagnosis
Colorectal Neoplasms/*diagnosis
Adult ; Aged ; COVID-19/epidemiology ; Early Detection of Cancer ; Female ; Humans ; Mass Screening/statistics & numerical data ; Middle Aged ; Netherlands/epidemiology ; Pandemics

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators.
Autorzy:: Muratov S; Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Canelo-Aybar C; Iberoamerican Cochrane Center, Instituto de Investigación Biomédica Sant Pau (IIB Sant Pau-CIBERESP), Barcelona, Spain.
Tarride JE; Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Alonso-Coello P; Iberoamerican Cochrane Center, Instituto de Investigación Biomédica Sant Pau (IIB Sant Pau-CIBERESP), Barcelona, Spain.
Dimitrova N; European Commission, Joint Research Centre, Via E. Fermi 2749 - TP 127, I-21027, Ispra, VA, Italy. .
Borisch B; Institute of Global Health, University of Geneva, Geneva, Switzerland.
Castells X; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Duffy SW; Queen Mary University of London, London, UK.
Fitzpatrick P; National Screening Service, Dublin, Ireland.; UCD School of Public Health, Physiotherapy & Sports Science, Dublin, Ireland.
Follmann M; German Cancer Society, Berlin, Germany.
Giordano L; CPO-Piedmont - AOU Città della Salute e della Scienza, Torino, Italy.
Hofvind S; Cancer Registry of Norway, Oslo, Norway.
Lebeau A; University Medical Center Hamburg-Eppendorf and Private Group Practice for Pathology, Hamburg, Germany.
Quinn C; St. Vincent's University Hospital, Dublin, Ireland.
Torresin A; ASST Grande Ospedale Metropolitano, Milan, Italy.
Vialli C; European Commission, Joint Research Centre, Via E. Fermi 2749 - TP 127, I-21027, Ispra, VA, Italy.
Siesling S; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, Netherlands.; University of Twente, Enschede, Netherlands.
Ponti A; CPO-Piedmont - AOU Città della Salute e della Scienza, Torino, Italy.
Giorgi Rossi P; AUSL Reggio Emilia, IRCCS, Reggio Emilia, Italy.
Schünemann H; Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Nyström L; Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden.
Broeders M; Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands. .; Pokaż więcej
Corporate Authors:: ECIBC contributor group
Źródło:: BMC cancer [BMC Cancer] 2020 Aug 24; Vol. 20 (1), pp. 795. Date of Electronic Publication: 2020 Aug 24.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms/*diagnosis
Early Detection of Cancer/*statistics & numerical data
Health Plan Implementation/*standards
Mass Screening/*organization & administration
Quality Indicators, Health Care/*standards
Aged ; Biopsy ; Breast/pathology ; Breast/surgery ; Breast Neoplasms/mortality ; Breast Neoplasms/prevention & control ; Breast Neoplasms/surgery ; Early Detection of Cancer/standards ; Europe/epidemiology ; Female ; Health Plan Implementation/statistics & numerical data ; Humans ; Mammography/standards ; Mammography/statistics & numerical data ; Mass Screening/standards ; Mass Screening/statistics & numerical data ; Mastectomy/statistics & numerical data ; Middle Aged ; Patient Acceptance of Health Care/statistics & numerical data ; Practice Guidelines as Topic ; Program Evaluation ; Quality Indicators, Health Care/statistics & numerical data ; Time Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: An actualised population-based study on the use of radiotherapy in breast cancer patients in the Netherlands.
Autorzy:: Schreuder K; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands.; Scientific Committee NABON Breast Cancer Audit (NBCA), The Netherlands.
Middelburg JG; Department of Radiation Oncology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Aarts MJ; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Merkus JWS; Department of Surgery, Haga Hospital, The Hague, The Netherlands.
Poortmans PMP; Department of Radiation Oncology, Institut Curie, Paris, France.
Jobsen JJ; Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands.
Siesling S; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands.; Scientific Committee NABON Breast Cancer Audit (NBCA), The Netherlands.
Struikmans H; Scientific Committee NABON Breast Cancer Audit (NBCA), The Netherlands.; Department of Radiation Oncology, Leiden University Medical Centre, Leiden, The Netherlands.; Pokaż więcej
Źródło:: The breast journal [Breast J] 2019 Sep; Vol. 25 (5), pp. 942-947. Date of Electronic Publication: 2019 Jun 04.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms/*radiotherapy
Radiotherapy/*statistics & numerical data
Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/pathology ; Breast Neoplasms/surgery ; Female ; Humans ; Mastectomy, Segmental/statistics & numerical data ; Middle Aged ; Netherlands

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the Netherlands.
Autorzy:: van Steenbeek CD; Department of Research, Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, Utrecht, DT, 3511, The Netherlands.; Department of Health Technology & Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Drienerlolaan 5, Enschede, NB, 7522, The Netherlands.
van Maaren MC; Department of Research, Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, Utrecht, DT, 3511, The Netherlands. .; Department of Health Technology & Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Drienerlolaan 5, Enschede, NB, 7522, The Netherlands. .
Siesling S; Department of Research, Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, Utrecht, DT, 3511, The Netherlands.; Department of Health Technology & Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Drienerlolaan 5, Enschede, NB, 7522, The Netherlands.
Witteveen A; Department of Research, Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, Utrecht, DT, 3511, The Netherlands.; Department of Health Technology & Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Drienerlolaan 5, Enschede, NB, 7522, The Netherlands.
Verbeek XAAM; Department of Research, Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, Utrecht, DT, 3511, The Netherlands.
Koffijberg H; Department of Health Technology & Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Drienerlolaan 5, Enschede, NB, 7522, The Netherlands. .; Pokaż więcej
Źródło:: BMC medical research methodology [BMC Med Res Methodol] 2019 Jun 08; Vol. 19 (1), pp. 117. Date of Electronic Publication: 2019 Jun 08.
Typ publikacji:: Journal Article
MeSH Terms:: Validation Studies as Topic*
Breast Neoplasms/*epidemiology
Area Under Curve ; Breast Neoplasms/mortality ; Databases, Factual ; Female ; Humans ; Models, Biological ; Netherlands/epidemiology ; Prognosis ; Registries

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: A conditional model predicting the 10-year annual extra mortality risk compared to the general population: a large population-based study in Dutch breast cancer patients.
Autorzy:: van Maaren MC; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.; Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, the Netherlands.
Kneepkens RF; Achmea Pension & Life, Tilburg, the Netherlands.
Verbaan J; De Hoop Life Reinsurance, the Hague, the Netherlands.
Huijgens PC; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
Lemmens VEPP; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.; Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.
Verhoeven RHA; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
Siesling S; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.; Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, the Netherlands.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2019 Jan 24; Vol. 14 (1), pp. e0210887. Date of Electronic Publication: 2019 Jan 24 (Print Publication: 2019).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms:: Breast Neoplasms/*mortality
Adult ; Aged ; Female ; Humans ; Insurance, Life/statistics & numerical data ; Logistic Models ; Middle Aged ; Models, Statistical ; Multivariate Analysis ; Netherlands/epidemiology ; Prospective Studies ; Registries ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Risk-based breast cancer follow-up stratified by age.
Autorzy:: Witteveen A; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands.
Otten JWM; Department of Stochastic Operations Research, University of Twente, Enschede, The Netherlands.
Vliegen IMH; Department of Industrial Engineering and Innovation Sciences, Eindhoven University of Technology, Eindhoven, The Netherlands.
Siesling S; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Timmer JB; Department of Stochastic Operations Research, University of Twente, Enschede, The Netherlands.
IJzerman MJ; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands.; Faculty of Medicine, Dentistry and Health Sciences, School of Population and Global Health, University of Melbourne and Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2018 Oct; Vol. 7 (10), pp. 5291-5298. Date of Electronic Publication: 2018 Sep 11.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms/*diagnosis
Neoplasm Recurrence, Local/*diagnosis
Adult ; Aftercare ; Age Distribution ; Aged ; Breast Neoplasms/therapy ; Early Detection of Cancer ; Female ; Humans ; Life Expectancy ; Markov Chains ; Middle Aged ; Neoplasm Recurrence, Local/therapy ; Netherlands ; Office Visits ; Practice Guidelines as Topic ; Registries ; Risk Assessment

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening.
Autorzy:: Sankatsing VDV; Department of Public Health, Erasmus MC, PO Box 2040, Rotterdam, 3015, CN, The Netherlands. .
Fracheboud J; Department of Public Health, Erasmus MC, PO Box 2040, Rotterdam, 3015, CN, The Netherlands.
de Munck L; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), PO Box 19079, Utrecht, 3501, DB, The Netherlands.
Broeders MJM; Department for Health Evidence, Radboud University Medical Center, PO Box 9101, Nijmegen, 6500, HB, The Netherlands.; Dutch Reference Center for Screening, PO Box 6873, Nijmegen, 6503, GJ, The Netherlands.
van Ravesteyn NT; Department of Public Health, Erasmus MC, PO Box 2040, Rotterdam, 3015, CN, The Netherlands.
Heijnsdijk EAM; Department of Public Health, Erasmus MC, PO Box 2040, Rotterdam, 3015, CN, The Netherlands.
Verbeek ALM; Department for Health Evidence, Radboud University Medical Center, PO Box 9101, Nijmegen, 6500, HB, The Netherlands.
Otten JDM; Department for Health Evidence, Radboud University Medical Center, PO Box 9101, Nijmegen, 6500, HB, The Netherlands.
Pijnappel RM; Dutch Reference Center for Screening, PO Box 6873, Nijmegen, 6503, GJ, The Netherlands.; Department of Radiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Siesling S; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), PO Box 19079, Utrecht, 3501, DB, The Netherlands.; Department of Health Technology & Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, Enschede, 7500, AE, The Netherlands.
de Koning HJ; Department of Public Health, Erasmus MC, PO Box 2040, Rotterdam, 3015, CN, The Netherlands.; Pokaż więcej
Corporate Authors:: National Evaluation Team for Breast cancer screening, NETB
Źródło:: BMC cancer [BMC Cancer] 2018 Mar 05; Vol. 18 (1), pp. 256. Date of Electronic Publication: 2018 Mar 05.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Early Detection of Cancer*
Breast Neoplasms/*diagnosis
Breast Neoplasms/*diagnostic imaging
Mammography/*methods
Aged ; Breast Neoplasms/epidemiology ; Ethnicity ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Netherlands/epidemiology ; Prognosis ; Registries

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Shifting breast cancer surveillance from current hospital setting to a community based setting: a cost-effectiveness study.
Autorzy:: de Ligt KM; Dept. of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511, DT, Utrecht, the Netherlands. .; Dept. of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Techical Medicine, University of Twente, Drienerlolaan 5, 7522, NB, Enschede, the Netherlands. .
Witteveen A; Dept. of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Techical Medicine, University of Twente, Drienerlolaan 5, 7522, NB, Enschede, the Netherlands.
Siesling S; Dept. of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511, DT, Utrecht, the Netherlands.; Dept. of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Techical Medicine, University of Twente, Drienerlolaan 5, 7522, NB, Enschede, the Netherlands.
Steuten LMG; Fred Hutchinson Cancer Research Center, HICOR: Hutchinson Institute for Cancer Outcomes Research, 1100 Fairview Ave. N, Seattle, WA, 98109, USA.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2018 Jan 24; Vol. 18 (1), pp. 96. Date of Electronic Publication: 2018 Jan 24.
Typ publikacji:: Journal Article
MeSH Terms:: Early Detection of Cancer*
Breast Neoplasms/*diagnosis
Breast Neoplasms/*epidemiology
Neoplasm Recurrence, Local/*epidemiology
Aged ; Breast/diagnostic imaging ; Breast/pathology ; Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/pathology ; Female ; Humans ; Mammography ; Mass Screening/methods ; Middle Aged ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/pathology ; Netherlands/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Survival after locoregional recurrence or second primary breast cancer: impact of the disease-free interval.
Autorzy:: Witteveen A; Department of Health Technology and Services Research, MIRA Institute of Biomedical Technology and Technical Medicine, Twente University, Enschede, The Netherlands.
Kwast AB; Department of Registration and Research, Comprehensive Cancer Centre the Netherlands (IKNL), Utrecht, the Netherlands.
Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
IJzerman MJ; Department of Health Technology and Services Research, MIRA Institute of Biomedical Technology and Technical Medicine, Twente University, Enschede, The Netherlands.
Siesling S; Department of Health Technology and Services Research, MIRA Institute of Biomedical Technology and Technical Medicine, Twente University, Enschede, The Netherlands; Department of Registration and Research, Comprehensive Cancer Centre the Netherlands (IKNL), Utrecht, the Netherlands.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 Apr 10; Vol. 10 (4), pp. e0120832. Date of Electronic Publication: 2015 Apr 10 (Print Publication: 2015).
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms/*mortality
Neoplasms, Second Primary/*mortality
Adult ; Aged ; Breast Neoplasms/pathology ; Breast Neoplasms/therapy ; Disease-Free Survival ; Female ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Neoplasm Recurrence, Local ; Neoplasms, Second Primary/pathology ; Neoplasms, Second Primary/therapy ; Prognosis ; Proportional Hazards Models

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Validation of death prediction after breast cancer relapses using joint models.
Autorzy:: Mauguen A; Biostatistic unit, INSERM U897, ISPED, Université de Bordeaux, 146 rue Léo Saignat, Bordeaux Cedex, 33076, France. .; Cancer Research UK Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT, London, UK. .
Rachet B; Cancer Research UK Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT, London, UK. .
Mathoulin-Pélissier S; Clinical epidemiology and research, Institut Bergonié, 229 Cours de l'Argonne, Bordeaux, 33000, France. .; INSERM CIC-EC7, ISPED, Université de Bordeaux, 146 rue Léo Saignat, Bordeaux Cedex, 33076, France. .
Lawrence GM; West Midlands Cancer Intelligence Unit, 5, St Philip's Place, Birmingham, B3 2PW, UK. .
Siesling S; Comprehensive Cancer Centre The Netherlands (IKNL), Godebaldkwartier 419 ingang Janssoenborch, Utrecht, 3511, The Netherlands. S.Siesling@iknl.nl.
MacGrogan G; Clinical epidemiology and research, Institut Bergonié, 229 Cours de l'Argonne, Bordeaux, 33000, France. .
Laurent A; Biostatistic unit, INSERM U897, ISPED, Université de Bordeaux, 146 rue Léo Saignat, Bordeaux Cedex, 33076, France. .
Rondeau V; Biostatistic unit, INSERM U897, ISPED, Université de Bordeaux, 146 rue Léo Saignat, Bordeaux Cedex, 33076, France. .; Pokaż więcej
Źródło:: BMC medical research methodology [BMC Med Res Methodol] 2015 Apr 01; Vol. 15, pp. 27. Date of Electronic Publication: 2015 Apr 01.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms:: Neoplasm Recurrence, Local*
Breast Neoplasms/*pathology
Risk Assessment/*methods
Risk Assessment/*statistics & numerical data
Adult ; Breast Neoplasms/mortality ; Female ; Humans ; Middle Aged ; Models, Theoretical ; Prognosis ; Proportional Hazards Models ; Reproducibility of Results ; Risk Factors ; Survival Analysis ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Regional variation in breast cancer treatment in the Netherlands and the role of external peer review: a cohort study comprising 63,516 women.
Autorzy:: Kilsdonk MJ; Comprehensive Cancer Centre the Netherlands, Department of Research, Postbus 19079, 3501 DB Utrecht, The Netherlands. .
van Dijk BA
Otter R
van Harten WH
Siesling S; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2014 Aug 16; Vol. 14, pp. 596. Date of Electronic Publication: 2014 Aug 16.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Peer Review, Health Care*
Breast Neoplasms/*therapy
Breast Neoplasms/epidemiology ; Breast Neoplasms/pathology ; Cohort Studies ; Drug Therapy ; Female ; Hospitals ; Humans ; Mastectomy, Segmental ; Netherlands/epidemiology ; Quality Assurance, Health Care ; Radiotherapy ; Sentinel Lymph Node Biopsy

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Siesling S"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język